Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-38.14	23.10	37.35
Graham Fair Price	253.19	11163.93	3160.91
PEG	-99.42	< 0.005	-1.30
Price/Book	-6.30	1.18	1.26
Price/Cash Flow	-16.49	20.64	24.71
Prices/Earnings	-92.33	8.62	112.28
Price/Sales	-15.73	2.01	2.39
Price/FCF	-16.49	20.64	24.71
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.96	0.50	0.49
Operating Margin	111.90	0.10	0.05
ROA	1017.47	0.02	< 0.005
ROE	< 0.005	0.03	1120.84
ROIC	< 0.005	0.03	616.63
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.12	0.19	-37.23
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.04	1.38	3092.01
EPS QOQ	-0.86	11.34	1212.37
FCF QOQ	3.42	0.13	-96.08
Revenue QOQ	0.09	0.12	34.57
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	132.37	134.81	1.84
Days Sales Outstanding (DSO)	46.90	40.70	-13.22
Inventory Turnover	0.68	0.67	-1.81
Debt/Capitalization	0.35	0.38	6.76
Quick Ratio	0.57	0.61	7.17
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12558.89	12694.86	1.08
Cash	1416.78	2871.15	102.65
Capex	-444.36	-222.08	50.02
Free Cash Flow	642.59	728.78	13.41
Revenue	6645.25	7468.43	12.39
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.15	1.27	10.91
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.58	6.75	-29.55
Naive Interpretation	Member

06 - Financial Health · Weak

Rating